Type III Secretion Translocon Structure and Function
III型分泌易位子的结构和功能
基本信息
- 批准号:8701601
- 负责人:
- 金额:$ 23.78万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-01 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:Aeromonas hydrophilaAntibiotic ResistanceBacteremiaBacteriaBiological AssayBurn injuryBypassCell membraneCellsCorneal InjuryCysteineCytoplasmDataDevelopmentDiseaseDockingDrug TargetingEngineeringErythrocyte MembraneGeneticGenetic TechniquesHeartHospitalsImmune systemIn VitroInfectionInjection of therapeutic agentMapsMembraneMolecularMutationNatureNeedlesNosocomial InfectionsPasteurella pseudotuberculosisPatientsPneumoniaProcessProtein-Protein Interaction MapProteinsPseudomonas aeruginosaResistanceSeverity of illnessStructureSurfaceSyringesTechniquesTestingTherapeutic InterventionType III Secretion System PathwayVentilatorVirulence FactorsWorkantimicrobialcrosslinkdesigndisulfide bonddrug developmentefflux pumphybrid proteinin vivointerestloss of functionmortalitymutantneutrophilpathogenpreventpublic health relevanceresearch studyresistance mechanismsuccess
项目摘要
DESCRIPTION (provided by applicant): P. aeruginosa is a common cause of hospital-acquired infections. It uses a type III secretion system to directly inject effector proteins into targeted host cells, in particular neutrophils, thereby preventing clearance by the host immune system. Injection of effector proteins involves a specialized structure called the translocon, which consists of a pore in the host cell membrane that interacts with the tip of the type III secretion needle. While the translocon is critical for type III secretion function, it has been difficult to study biochemically. Here we propose to use a genetic technique to identify critical translocator interactions and categorize them according to their function in the translocation process (translocator insertion, pore formation, docking of the tip to the pore and triggering of effector secretion). Identifying translocator contacts that are critical for function not only increases our understanding of the translocon, it also identifies potential targets for therapeutic
intervention that lie outside of the bacterial cell and are therefore not shielded by conventional antibiotic resistance mechanisms, such as the outer membrane or efflux pumps.
描述(由申请方提供):铜绿假单胞菌是医院获得性感染的常见原因。它使用III型分泌系统将效应蛋白直接注入靶向宿主细胞,特别是嗜中性粒细胞,从而防止宿主免疫系统的清除。效应蛋白的注射涉及称为易位子的专门结构,其由宿主细胞膜中的孔组成,所述孔与III型分泌针的尖端相互作用。虽然易位子对于III型分泌功能是关键的,但它很难进行生物化学研究。在这里,我们建议使用一种遗传技术来确定关键的易位相互作用,并根据它们在易位过程中的功能(易位插入,孔形成,对接的尖端孔和触发效应分泌)进行分类。识别对功能至关重要的易位接触不仅增加了我们对易位子的理解,还确定了治疗的潜在靶点。
干预位于细菌细胞之外,因此不受常规抗生素耐药性机制(如外膜或外排泵)的屏蔽。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arne Rietsch其他文献
Arne Rietsch的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arne Rietsch', 18)}}的其他基金
Host cell factors controlling type III secretion effector translocation
控制III型分泌效应器易位的宿主细胞因子
- 批准号:
10416972 - 财政年份:2022
- 资助金额:
$ 23.78万 - 项目类别:
Host cell factors controlling type III secretion effector translocation
控制III型分泌效应器易位的宿主细胞因子
- 批准号:
10586145 - 财政年份:2022
- 资助金额:
$ 23.78万 - 项目类别:
Development of recombinase-based tools to study established infections
开发基于重组酶的工具来研究已确定的感染
- 批准号:
10201472 - 财政年份:2020
- 资助金额:
$ 23.78万 - 项目类别:
Development of recombinase-based tools to study established infections
开发基于重组酶的工具来研究已确定的感染
- 批准号:
10040615 - 财政年份:2020
- 资助金额:
$ 23.78万 - 项目类别:
P. aeruginosa type III secreted effectors in corneal disease
角膜疾病中铜绿假单胞菌 III 型分泌效应子
- 批准号:
8404007 - 财政年份:2012
- 资助金额:
$ 23.78万 - 项目类别:
P. aeruginosa type III secreted effectors in corneal disease
角膜疾病中铜绿假单胞菌 III 型分泌效应子
- 批准号:
8962457 - 财政年份:2012
- 资助金额:
$ 23.78万 - 项目类别:
P. aeruginosa type III secreted effectors in corneal disease
角膜疾病中铜绿假单胞菌 III 型分泌效应子
- 批准号:
8217524 - 财政年份:2012
- 资助金额:
$ 23.78万 - 项目类别:
P. aeruginosa type III secreted effectors in corneal disease
角膜疾病中铜绿假单胞菌 III 型分泌效应子
- 批准号:
8597435 - 财政年份:2012
- 资助金额:
$ 23.78万 - 项目类别:
P. aeruginosa type III secreted effectors in corneal disease
角膜疾病中铜绿假单胞菌 III 型分泌效应子
- 批准号:
9115162 - 财政年份:2012
- 资助金额:
$ 23.78万 - 项目类别:
相似海外基金
Ecological and Evolutionary Drivers of Antibiotic Resistance in Patients
患者抗生素耐药性的生态和进化驱动因素
- 批准号:
EP/Y031067/1 - 财政年份:2024
- 资助金额:
$ 23.78万 - 项目类别:
Research Grant
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
- 批准号:
2307222 - 财政年份:2024
- 资助金额:
$ 23.78万 - 项目类别:
Standard Grant
Molecular Epidemiology of Antibiotic Resistance in Clostridioides difficile
艰难梭菌抗生素耐药性的分子流行病学
- 批准号:
502587 - 财政年份:2024
- 资助金额:
$ 23.78万 - 项目类别:
Collaborative Research: Leveraging the interactions between carbon nanomaterials and DNA molecules for mitigating antibiotic resistance
合作研究:利用碳纳米材料和 DNA 分子之间的相互作用来减轻抗生素耐药性
- 批准号:
2307223 - 财政年份:2024
- 资助金额:
$ 23.78万 - 项目类别:
Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
- 批准号:
MR/Y013131/1 - 财政年份:2024
- 资助金额:
$ 23.78万 - 项目类别:
Research Grant
Determining structural dynamics of membrane proteins in their native environment: focus on bacterial antibiotic resistance
确定膜蛋白在其天然环境中的结构动力学:关注细菌抗生素耐药性
- 批准号:
MR/X009580/1 - 财政年份:2024
- 资助金额:
$ 23.78万 - 项目类别:
Fellowship
CAREER: Systems Microbiology and InterdiscipLinary Education for Halting Environmental Antibiotic Resistance Transmission (SMILE HEART)
职业:阻止环境抗生素耐药性传播的系统微生物学和跨学科教育(SMILE HEART)
- 批准号:
2340818 - 财政年份:2024
- 资助金额:
$ 23.78万 - 项目类别:
Continuing Grant
Reinforcing the battle at the bacterial cell wall: Structure-guided characterization and inhibition of beta-lactam antibiotic resistance signalling mechanisms
加强细菌细胞壁的战斗:β-内酰胺抗生素耐药信号机制的结构引导表征和抑制
- 批准号:
480022 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Operating Grants
The spread of antibiotic resistance in bacteria-plasmid networks
抗生素耐药性在细菌-质粒网络中的传播
- 批准号:
BB/X010473/1 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别:
Fellowship
An RNA Nanosensor for the Diagnosis of Antibiotic Resistance in M. Tuberculosis
用于诊断结核分枝杆菌抗生素耐药性的 RNA 纳米传感器
- 批准号:
10670613 - 财政年份:2023
- 资助金额:
$ 23.78万 - 项目类别: